Coughing up blood, known medically as hemoptysis, can range from minor blood-streaked sputum to a massive, life-threatening event. When hemoptysis is severe or recurrent, bronchial artery embolization has become a well-established interventional radiology technique for controlling the bleeding at its vascular source. Because the underlying causes of hemoptysis vary widely — from infections to tumors to chronic lung disease — understanding how this procedure fits into the broader management picture is useful for patients and families facing this diagnosis.
Why Are the Bronchial Arteries the Target?
In most cases of significant hemoptysis, the bleeding originates not from the pulmonary arteries (which carry deoxygenated blood to the lungs at relatively low pressure) but from the bronchial arteries, a separate, higher-pressure arterial system that supplies the airways themselves and can become abnormally enlarged and fragile in the setting of chronic lung conditions such as bronchiectasis, prior infections like tuberculosis, or certain tumors. This higher-pressure bronchial circulation is generally considered the more common source of significant hemoptysis, which is why embolization efforts are typically directed there first.
What Happens During Bronchial Artery Embolization?
The procedure begins with arterial access, typically through the femoral artery, followed by selective angiography of the bronchial arteries to identify abnormal, enlarged, or actively bleeding vessels. Because bronchial artery anatomy varies considerably between individuals — including variable numbers of bronchial arteries and sometimes non-bronchial systemic collateral vessels also contributing to lung blood supply — thorough angiographic mapping is an important part of the procedure. Once abnormal vessels are identified, embolic material is deployed to occlude the vessels contributing to bleeding.
Why Is Careful Technique Especially Important Here?
The bronchial arteries can, in some patients, share connections with the spinal arteries supplying the spinal cord, which makes careful angiographic assessment and technique particularly important to avoid inadvertent non-target embolization that could affect spinal cord blood supply. Experienced operators pay close attention to angiographic anatomy before embolizing, and this anatomical consideration is one of the more technically demanding aspects of bronchial artery embolization compared with embolization in some other parts of the body.
What Can Patients Expect Regarding Effectiveness and Recurrence?
Bronchial artery embolization is generally reported in the interventional radiology literature as an effective technique for achieving short-term control of hemoptysis in a majority of appropriately selected patients. However, because the underlying lung disease causing the abnormal vessels often remains present, recurrent bleeding can occur over time in some patients, sometimes from the same vessels re-establishing collateral flow or from previously untreated vessels. Ongoing management of the underlying pulmonary condition remains an important part of long-term care alongside the embolization procedure itself.
What Does Recovery Typically Involve?
Recovery from the embolization procedure itself is generally brief, with most patients monitored for a period afterward and many returning home within a day or two, depending on their overall clinical status and the severity of the underlying lung condition. Ongoing pulmonary evaluation and management of the cause of hemoptysis typically continues after the embolization procedure, coordinated between pulmonology and interventional radiology teams.
Embolization Technologies Supporting Lung Hemorrhage Control
Controlling bronchial artery bleeding requires embolic devices suited to the vessel sizes and flow characteristics typically encountered in this vascular territory. INVAMED manufactures a range of embolization technologies used across interventional radiology applications, including coil and catheter systems relevant to bronchial and other vascular embolization procedures; further information is available on the INVAMED embolization products page. Availability and indications vary by country, and the Instructions for Use (IFU) should always be consulted.
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.